Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-LAR/PTPRF Antibody (N165/38)

Catalog #:   RHC81401 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ICC, IF, IHC, WB
Overview

Catalog No.

RHC81401

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

Leukocyte common antigen related, Receptor-type tyrosine-protein phosphatase F, PTPRF, LAR

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

ICC, IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

N165/38

Data Image
References

Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy., PMID:40402266

Cancer recurrence risk with bDMARD treatment in patients with rheumatoid arthritis and a history of cancer: a nationwide Danish register-based cohort study., PMID:40254339

Local controlled release of stabilized monoclonal antibodies., PMID:40250626

Local allergic rhinitis in Asia: rethinking the allergy landscape., PMID:40167188

Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review., PMID:40124876

Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial., PMID:39978376

RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer., PMID:39972124

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial., PMID:39762422

SARS-CoV-2 seroprevalence and associated factors among outpatient attendees at health facilities in different provinces in Chad., PMID:39529023

Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer., PMID:39287044

Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study., PMID:39265540

Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial., PMID:39060015

Growth of White Leghorn Chicken Immune Organs after Long-Term Divergent Selection for High or Low Antibody Response to Sheep Red Blood Cells., PMID:38791704

Challenging diagnosis of resistance to thyroid hormone in a patient with COVID-19, pituitary microadenoma and unusual response to octreotide long-acting release test., PMID:38642577

Local Allergic Rhinitis., PMID:38641133

Yingxiang Acupoint Embedding Improves Mucosal Barrier Function in Rats with Local Allergic Rhinitis., PMID:38588639

Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis., PMID:38483174

Local allergic rhinitis - a narrative review., PMID:38375713

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings., PMID:38316982

AIT 2023: Current innovation and future outlook., PMID:38143940

Comparison of the immunogenicity and safety of Euvichol-Plus with Shanchol in healthy Indian adults and children: an open-label, randomised, multicentre, non-inferiority, parallel-group, phase 3 trial., PMID:38076719

Elevated serum lactate dehydrogenase to albumin ratio is a useful poor prognostic predictor of nivolumab in patients with non-small cell lung cancer., PMID:37869953

Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma., PMID:37790933

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro., PMID:37771376

LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab., PMID:37713583

Is the Androgen Receptor a Viable Target in Triple Negative Breast Cancer in 5 Years?, PMID:37419745

Targeting triple-negative breast cancer: A clinical perspective., PMID:37305385

Challenges in Local Allergic Rhinitis Diagnosis, Management, and Research: Current Concepts and Future Perspectives., PMID:37241161

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma., PMID:36822634

Single cell multi-omic reference atlases of non-human primate immune tissues reveals CD102 as a biomarker for long-lived plasma cells., PMID:36543997

Local Allergic Rhinitis: Lights and Shadows of a Mysterious Entity., PMID:36223735

Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study., PMID:36123126

Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation., PMID:35867145

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis., PMID:35816437

Sequential class switch recombination to IgE and allergen-induced accumulation of IgE+ plasmablasts occur in the nasal mucosa of local allergic rhinitis patients., PMID:35340036

Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer., PMID:35240902

Risk of Chronic Rhinosinusitis With Nasal Polyps in Endotypes of Dermatophagoides pteronyssinus-Induced Rhinitis., PMID:35074602

Triple-negative Breast Cancer (TNBC) and Its Luminal Androgen Receptor (LAR) Subtype: A Clinicopathologic Review of Cases in a University Hospital in Northwestern Nigeria., PMID:35046202

Association of MHCY genotypes in lines of chickens divergently selected for high or low antibody response to sheep red blood cells., PMID:34995879

First report of a confirmed case of Montivipera latifii (Latifi's viper) envenoming and a literature review of envenoming by Montivipera species., PMID:34995557

High-valency Anti-CD99 Antibodies Toward the Treatment of T Cell Acute Lymphoblastic Leukemia., PMID:34958778

[Impact of immune inflammation on the proliferation and apoptosis of benign prostatic hyperplasia cells]., PMID:34914263

Distribution of cholinergic neurons in the brains of a lar gibbon and a chimpanzee., PMID:34837339

Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue., PMID:34663881

Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation., PMID:34320837

An Elevated Serum Lactate Dehydrogenase-to-albumin Ratio Is a Useful Poor Prognostic Predictor of Nivolumab in Patients With Gastric Cancer., PMID:34281855

Triple-Negative Breast Cancer: Breast Tumors With an Identity Crisis., PMID:33475287

Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS., PMID:33408167

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade., PMID:33157048

Local allergic rhinitis: a pediatric perspective., PMID:33108072

Datasheet
$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-LAR/PTPRF Antibody (N165/38) [RHC81401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only